A genetic reduction in the serotonin transporter differentially influences MDMA and heroin induced behaviours

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Psychopharmacology

• Publication date

  2018-03-21

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-018-4880-1PMID 29560525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haplo-Insufficiency or Knockout of the Serotonin Transporter Does not Affect Heroin Self-Administration but Decreases BDNF in the Frontal Cortex

  2018cited by this paper
• SERT and uncertainty: serotonin transporter expression influences information processing biases for ambiguous aversive cues in mice

  2015cited by this paper
• Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice.

  2015cited by this paper
• A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats

  2014cited by this paper
• Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.

  2014cited by this paper
• Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

  2014cited by this paper
• Neurocircuitry of drug reward.

  2014cited by this paper
• The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats

  2014cited by this paper
• From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists.

  2013cited by this paper
• onditioned taste aversion and drugs of abuse : History and interpretation

  2012cited by this paper
• Addiction circuitry in the human brain.

  2012cited by this paper
• Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)

  2012cited by this paper
• Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D1- and D2-like agonists

  2012cited by this paper
• MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?

  2012cited by this paper
• Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processes.

  2012cited by this paper
• Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions

  2011cited by this paper
• Opiate versus psychostimulant addiction: the differences do matter

  2011cited by this paper
• PRECLINICAL STUDY: FULL ARTICLE: Tolerance to 3,4‐methylenedioxymethamphetamine is associated with impaired serotonin release

  2010cited by this paper
• Conditioned saccharin avoidance and sensitization to drugs of abuse.

  2010cited by this paper
• Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats

  2009cited by this paper
• Repeated heroin in rats produces locomotor sensitization and enhances appetitive Pavlovian and instrumental learning involving food reward.

  2009cited by this paper
• Development of pharmacotherapies for drug addiction: a Rosetta Stone approach

  2009cited by this paper
• Imaging dopamine's role in drug abuse and addiction.

  2009cited by this paper
• Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats

  2008cited by this paper
• A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders.

  2008cited by this paper
• Acute and sensitized response to 3,4‐methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression

  2008cited by this paper
• STUDY IN MALE AND FEMALE 5-HT TRANSPORTER KNOCKOU ATS : AN ANIMAL MODEL FOR ANXIETY AND DEPRESSION

  2008cited by this paper
• 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.

  2007cited by this paper
• Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter

  2005cited by this paper
• Intravenous cocaine self-administration in rats is reduced by dietaryl-tryptophan

  2005cited by this paper
• 3,4-N-Methlenedioxymethamphetamine-Induced Hypophagia is Maintained in 5-HT1B Receptor Knockout Mice, but Suppressed by the 5-HT2C Receptor Antagonist RS102221

  2005cited by this paper
• The effects of morphine and Δ-9-tetrahydrocannabinol on motor activity in rats

  2004cited by this paper
• An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-Amphetamine and apomorphine

  2004cited by this paper
• Effect of α- and Β-adrenergic blocking agents and para-chlorophenylalanine on morphine- and caffeine-stimulated locomotor activity of mice

  2004cited by this paper
• Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats

  2004cited by this paper
• Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.

  2003cited by this paper
• Monoamine transporters and psychostimulant drugs.

  2003cited by this paper
• Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine.

  2002cited by this paper
• Serotonin Transporter Genetic Variation and the Response of the Human Amygdala

  2002cited by this paper
• 5-HT2A and 5-HT2C/2B Receptor Subtypes Modulate Dopamine Release Induced in Vivo by Amphetamine and Morphine in Both the Rat Nucleus Accumbens and Striatum

  2002cited by this paper
• Incentive-sensitization and addiction.

  2001cited by this paper
• Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice.

  2001cited by this paper
• Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies

  2000cited by this paper
• Water-deprivation prevents morphine-, but not LiCl-induced, suppression of sucrose intake.

  1999cited by this paper
• Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.

  1998cited by this paper
• Fluoxetine attenuates morphine-induced locomotion and blocks morphine-sensitization.

  1997cited by this paper
• Conditioned taste aversions and drugs of abuse: a reinterpretation.

  1997cited by this paper
• Serotonin1B receptor stimulation enhances dopamine-mediated reinforcement

  1996cited by this paper
• Rewarding drugs produce taste avoidance, but not taste aversion.

  1995cited by this paper
• The neural basis of drug craving: an incentive-sensitization theory of addiction.

  1993cited by this paper
• Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.

  1992cited by this paper
• Fluoxetine reduces intravenous cocaine self-administration in rats.

  1990cited by this paper
• Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.

  1990cited by this paper
• Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

  1988cited by this paper
• Conditioned taste aversion induced by self-administered drugs: paradox revisited.

  1987cited by this paper
• Effects of opiate antagonist treatment into either the periaqueductal grey or nucleus accumbens on heroin-induced locomotor activation.

  1987cited by this paper
• Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.

  1987cited by this paper
• Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat.

  1985cited by this paper
• The role of dopamine in locomotor activity and learning.

  1983cited by this paper
• The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.

  1982cited by this paper
• Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.

  1981cited by this paper
• Aversive stimulus properties of drugs.

  1979cited by this paper
• Dopamine agonists: their effect on locomotion and exploration.

  1978cited by this paper
• Parametric investigations of the effects of prior exposure to amphetamine and morphine on conditioned gustatory aversion

  1977cited by this paper
• Effect of humoral modulators of morphine-induced increase in locomotor activity of mice.

  1976cited by this paper
• The Open-Field Test: a critical review.

  1976cited by this paper
• Biphasic effects of morphine of locomotor activity and brain acetylcholine utilization in non tolerant rats

  1974cited by this paper
• Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens

  1973cited by this paper
• Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

  1970cited by this paper
• On the presence of 3-hydroxytyramine in brain.

  1958cited by this paper

• 3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2)‐deficient rats lacking serotonin in the central nervous system

  2025cites this paper
• Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.

  2024cites this paper
• Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability.

  2022cites this paper
• Genetics and epigenetics: paternal adolescent ethanol consumption in serotonin transporter knock-out rats and offspring sensitivity to ethanol

  2022cites this paper
• Impact of fluoxetine preexposure on MDMA-induced taste avoidance in male and female rats.

  2022cites this paper
• Genetic Knockout of the Serotonin Reuptake Transporter Results in the Reduction of Dendritic Spines in In vitro Rat Cortical Neuronal Culture

  2021cites this paper
• Role of the Serotonin 2B Receptor in the Reinforcing Effects of Psychostimulants

  2021cites this paper
• Pharmacodynamic Evaluation: Drug Dependency and Addiction

  2020cites this paper
• A genetic deletion of the serotonin transporter differentially influences the behavioural effects of MDMA

  2019cites this paper
• Pharmacodynamic Evaluation : Drug Dependency and Addiction

  2018cites this paper